Dihydroergotamine Mesylate 5 mg/Metoclopramide 5 mg Troche is a specially compounded medication designed to address a range of conditions such as migraine headaches, nausea, and vomiting. This unique formulation brings together two potent active ingredients - dihydroergotamine mesylate and metoclopramide - to create a highly effective treatment option.

Dihydroergotamine mesylate functions as a vasoconstrictor, reducing the severity of migraine headaches by narrowing the blood vessels in the brain. On the other hand, metoclopramide acts as a dopamine antagonist, effectively reducing instances of nausea and vomiting by blocking the dopamine receptors in the brain that trigger these symptoms.

This combination of medications is presented in a troche form, a square-shaped solid dosage form designed to dissolve slowly in the mouth. The medication is delivered through oral mucosa absorption, allowing for targeted local or systemic effects. This method of delivery not only ensures quick absorption but also makes the medication easy to take, providing rapid relief from migraine headaches, nausea, and vomiting.

If you have any queries about this formulation or how it can assist in managing your condition, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is always ready to help you find the most suitable treatment for your condition.

This compounded formulation of Dihydroergotamine Mesylate 5 mg/Metoclopramide 5 mg Troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth. It delivers medication through oral mucosa absorption for targeted local or systemic effects. It is primarily used for the treatment of migraine headaches, nausea, and vomiting.

However, it is crucial to note that this formulation should not be used in patients with a history of coronary artery disease, peripheral vascular disease, or uncontrolled hypertension. It is also contraindicated in patients with a history of stroke, transient ischemic attack, or ischemic heart disease.

Patients should be advised to avoid activities that require alertness, such as driving or operating machinery, until they know how this formulation affects them. Alcohol consumption should also be avoided while taking this formulation, as it may increase the risk of side effects.

Patients should inform their healthcare provider if they are taking any other medications, including over-the-counter medications, vitamins, and herbal supplements, as these may interact with this formulation. It is also important to note that this formulation may cause drowsiness, dizziness, or blurred vision.

Patients should be advised to avoid getting up too quickly from a sitting or lying position, as this may cause dizziness. If you have any questions about this formulation or its interactions, please reach out to your healthcare provider.

Dihydroergotamine Mesylate 5 mg/Metoclopramide 5 mg Troche is a compounded medication specifically designed to alleviate the symptoms of migraine headaches, including associated nausea and vomiting. This unique formulation works by inhibiting the action of certain brain chemicals that trigger migraines. The Metoclopramide component of this medication further aids in reducing nausea and vomiting that often accompany migraines.

The medication is presented as a troche, a square-shaped solid dosage form that dissolves slowly in the mouth. This allows for the medication to be absorbed through the oral mucosa, providing targeted local or systemic effects. The troche should be taken at the first sign of a migraine for optimal effectiveness. Timely administration can significantly reduce the severity of the headache.

It is crucial to adhere to the directions provided on the prescription label. This medication should be taken exactly as prescribed by your healthcare provider. Avoid taking more or less of the medication than recommended, and do not exceed the prescribed frequency of administration.

If you have any queries or concerns regarding this medication or its mechanism of action, please do not hesitate to contact us. We are here to assist you in understanding your medication better and ensuring its effective use.

This compounded formulation of Dihydroergotamine Mesylate 5 mg/Metoclopramide 5 mg Troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth. The medication is delivered through oral mucosa absorption, targeting local or systemic effects. It is primarily used to treat conditions such as nausea and vomiting that may be caused by chemotherapy, radiation therapy, or other underlying causes. This formulation may also be beneficial for patients suffering from diabetic gastroparesis, a condition characterized by symptoms such as nausea, vomiting, and abdominal pain. Furthermore, it can be used to alleviate symptoms of gastroesophageal reflux disease (GERD), including heartburn, regurgitation, and difficulty swallowing. This formulation may also be effective in treating symptoms of functional dyspepsia, such as abdominal pain, bloating, and early satiety. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out for further information.